The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis

Published:2014-02-21 Issue:3 Volume:77 Page:446-457
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Floyd Christopher N.¹,Ferro Albert¹

Affiliation:

1. Department of Clinical Pharmacology; Cardiovascular Division; British Heart Foundation Centre of Research Excellence; King's College London; London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12204/fullpdf

Reference62 articles.

1. Some observations on the blood-clotting mechanism; the role of fibrinogen and platelets, with reference to a case of congenital afibrinogenaemia;Pinniger;Br J Exp Pathol,1946

2. The platelet fibrinogen receptor: from megakaryocyte to the mortuary;Floyd;J R Soc Med Cardiovasc Dis,2012

3. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets;Wagner;Blood,1996

4. Human platelet alloantigens: recent findings, new perspectives;Newman;Thromb Haemost,1995

5. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis;Simsek;Blood,1993

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet ADP receptor (P2RY1) polymorphism and the risk of inadequate platelet response to aspirin: Study in patients with ischemic stroke;2024-01-10

2. Genotype-guided dual antiplatelet therapy in cerebrovascular disease: assessing the risk and benefits for ethnic populations;Expert Review of Cardiovascular Therapy;2023-08-13

3. Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction;Rational Pharmacotherapy in Cardiology;2023-07-27

4. Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients;Molecular Diagnosis & Therapy;2021-08-06

5. Prevalence and types of genetic polymorphisms of CYP2C19 and their effects on platelet aggregation inhibition by clopidogrel;EUR REV MED PHARMACO;2020